RecruitingNot ApplicableNCT04793828

A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders

The Effect of a Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders


Sponsor

Charite University, Berlin, Germany

Enrollment

30 participants

Start Date

Jul 4, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder
  • Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires
  • Written informed consent
  • Internet access

Exclusion Criteria3

  • Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)
  • Acute suicidality
  • Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)

Interventions

BEHAVIORALVelibra

Velibra is an internet-based cognitive behavioral therapy program developed by GAIA AG. It consists of six modules which are meant to be completed over a span of 6 weeks. The first module educates participants about anxiety and the treatment program. The second module focuses on cognitive techniques for dealing with anxiety. In the third module, relaxation techniques are practiced. The fourth module encourages the participant to practice non-anxious behaviors. In the fifth module, the central topic is the experience of social situations in non-anxious ways. The sixth and final module consists of a summary and recapitulation of the most important content.


Locations(1)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04793828


Related Trials